Insider: Secora Michael Chief Financial Officer - RECURSION PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,499,631 | 0 | 1,499,631 |
| Value | $6,943,291.53 | $0.00 | $6,943,291.53 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/13/2024 | DDS | 15,000 | Direct | COM | $7.66 | $114,876.00 | 1,499,631 |
| 11/12/2024 | DDS | 15,000 | Direct | COM | $7.64 | $114,628.50 | 1,475,256 |
| 10/09/2024 | DDS | 15,000 | Direct | COM | $6.36 | $95,374.50 | 1,450,881 |
| 10/08/2024 | DDS | 15,000 | Direct | COM | $6.32 | $94,756.50 | 1,426,506 |
| 09/11/2024 | DDS | 15,000 | Direct | COM | $6.32 | $94,729.50 | 1,402,131 |
| 09/10/2024 | DDS | 15,000 | Direct | COM | $6.17 | $92,499.00 | 1,377,756 |
| 08/14/2024 | DDS | 15,000 | Direct | COM | $6.35 | $95,251.50 | 1,365,343 |
| 08/13/2024 | DDS | 15,000 | Direct | COM | $6.35 | $95,182.50 | 1,340,968 |
| 06/14/2024 | DDS | 15,000 | Direct | COM | $9.27 | $139,081.50 | 1,267,843 |
| 06/13/2024 | DDS | 15,000 | Direct | COM | $9.32 | $139,798.50 | 1,243,468 |
| 04/17/2024 | DDS | 23,124 | Direct | COM | $7.58 | $175,349.29 | 1,231,055 |
| 04/16/2024 | DDS | 25,000 | Direct | COM | $7.67 | $191,657.50 | 1,216,679 |
| 03/13/2024 | DDS | 25,000 | Direct | COM | $11.03 | $275,815.00 | 1,204,179 |
| 03/12/2024 | DDS | 25,000 | Direct | COM | $10.46 | $261,375.00 | 1,191,679 |
| 02/14/2024 | DDS | 1,067 | Direct | COM | $10.98 | $11,720.03 | 1,186,351 |
| 02/14/2024 | DDS | 23,933 | Direct | COM | $10.43 | $249,704.96 | 1,187,418 |
| 02/13/2024 | DDS | 25,000 | Direct | COM | $9.86 | $246,560.00 | 1,173,851 |
| 01/17/2024 | DDS | 25,000 | Direct | COM | $10.25 | $256,347.50 | 981,014 |
| 01/16/2024 | DDS | 25,000 | Direct | COM | $10.45 | $261,160.00 | 968,514 |
| 12/13/2023 | DDS | 25,000 | Direct | COM | $7.59 | $189,770.00 | 956,014 |
| 12/12/2023 | DDS | 25,000 | Direct | COM | $7.39 | $184,867.50 | 943,514 |
| 11/15/2023 | DDS | 20,300 | Direct | COM | $7.25 | $147,187.18 | 942,886 |
| 11/15/2023 | DDS | 4,700 | Direct | COM | $7.62 | $35,798.96 | 938,186 |
| 11/14/2023 | DDS | 25,000 | Direct | COM | $6.32 | $157,942.50 | 925,686 |
| 10/11/2023 | DDS | 25,000 | Direct | COM | $6.85 | $171,312.50 | 913,186 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research